Search Articles :
Re-size text: Decrease Text Size Increase Text Size

Gynecologic Oncology Specialist Joins The Stephenson Cancer Center

Monday, February 1, 2016 - Campus News -
HolmanLaura.jpg
 

Laura L. Holman, M.D., a gynecologic oncologist, has established her medical practice with the Stephenson Cancer Center. She has also been named an assistant professor with the University of Oklahoma College of Medicine. Gynecologic oncologists specialize in the diagnosis and treatment of cancers of the female reproductive tract, including the cervix, uterus, fallopian tubes, vagina, ovaries and peritoneum.

Holman completed a gynecologic oncology fellowship at the University of Texas MD Anderson Cancer Center, Houston. She completed an obstetrics and gynecology residency at Women & Infants Hospital of Rhode Island, Warren Alpert Medical School of Brown University, Providence. She earned her medical degree at the University of Illinois at Chicago College of Medicine and earned a master’s degree in cancer biology from the University of Texas Graduate School of Biomedical Sciences.

For appointments with a gynecologic oncologist at the Stephenson Cancer Center, call (405) 271-8707.

Oklahoma’s only comprehensive academic cancer center, the Stephenson Cancer Center at the University of Oklahoma is a nationally noted leader in research and patient care. The Stephenson Cancer Center annually ranks among the top three cancer centers in the nation for patients participating in National Cancer Institute-sponsored treatment trials, and it is one of 30 designated lead centers nationally in the Institute’s National Clinical Trials Network. In collaboration with the Oklahoma Tobacco Settlement Endowment Trust, the Stephenson Cancer Center is decreasing the burden of cancer in Oklahoma by supporting innovative laboratory, clinical and populations-based research. The Stephenson Cancer Center has 200 research members who are conducting more than 165 cancer research projects at institutions across Oklahoma. This research is supported by $41.2 million in annual funding from the National Cancer Institute, the American Cancer Society and other sponsors.


Related Articles:

No Related Content Found



Related Materials